SG11202108033TA - Native microfluidic ce-ms analysis of antibody charge heterogeneity - Google Patents

Native microfluidic ce-ms analysis of antibody charge heterogeneity

Info

Publication number
SG11202108033TA
SG11202108033TA SG11202108033TA SG11202108033TA SG11202108033TA SG 11202108033T A SG11202108033T A SG 11202108033TA SG 11202108033T A SG11202108033T A SG 11202108033TA SG 11202108033T A SG11202108033T A SG 11202108033TA SG 11202108033T A SG11202108033T A SG 11202108033TA
Authority
SG
Singapore
Prior art keywords
microfluidic
native
analysis
charge heterogeneity
antibody charge
Prior art date
Application number
SG11202108033TA
Other languages
English (en)
Inventor
Hongxia Wang
Haibo Qiu
Ning Li
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG11202108033TA publication Critical patent/SG11202108033TA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40Concentrating samples
    • G01N1/4044Concentrating samples by chemical techniques; Digestion; Chemical decomposition
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11202108033TA 2019-01-31 2020-01-30 Native microfluidic ce-ms analysis of antibody charge heterogeneity SG11202108033TA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962799331P 2019-01-31 2019-01-31
US201962851365P 2019-05-22 2019-05-22
PCT/US2020/015875 WO2020160266A1 (en) 2019-01-31 2020-01-30 Native microfluidic ce-ms analysis of antibody charge heterogeneity

Publications (1)

Publication Number Publication Date
SG11202108033TA true SG11202108033TA (en) 2021-08-30

Family

ID=69811860

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202108033TA SG11202108033TA (en) 2019-01-31 2020-01-30 Native microfluidic ce-ms analysis of antibody charge heterogeneity

Country Status (12)

Country Link
US (1) US20200249241A1 (pt)
EP (1) EP3918339A1 (pt)
JP (1) JP2022519246A (pt)
KR (1) KR20210122803A (pt)
CN (1) CN113646638B (pt)
AU (1) AU2020216172A1 (pt)
BR (1) BR112021013716A2 (pt)
CA (1) CA3126712A1 (pt)
IL (1) IL284929A (pt)
MX (1) MX2021009267A (pt)
SG (1) SG11202108033TA (pt)
WO (1) WO2020160266A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114544839B (zh) * 2022-01-20 2024-08-20 未名生物医药有限公司 一种抗人神经生长因子抗体的电荷变异体检测方法
TW202346856A (zh) * 2022-03-18 2023-12-01 美商里珍納龍藥品有限公司 分析多肽變體的方法及系統
WO2024020199A1 (en) * 2022-07-21 2024-01-25 Regeneron Pharmaceuticals, Inc. Native microfluidic ce-ms analysis of antibody charge heterogeneity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1194768A4 (en) * 1999-04-20 2008-03-26 Target Discovery Inc FINGERPRINTING METHOD FOR POLYPEPTIDES, CREATING METABOLIC PROFILES, AND BIOINFORMATIVE DATABASE
FR2862134B1 (fr) * 2003-11-12 2007-07-27 Sebia Sa Analyse et typage de proteines monoclonales par electrophorese capillaire et immunodeplacement
CN101201355A (zh) * 2006-12-15 2008-06-18 许洋 免疫组质谱检测个体化肿瘤生物标志及疗效试剂盒和方法
US20100187113A1 (en) * 2009-01-26 2010-07-29 Vladislav Dolnik Capillary sieving electrophoresis with a cationic surfactant for size separation of proteins
EP3916011A1 (en) 2009-06-26 2021-12-01 Regeneron Pharmaceuticals, Inc. Readily isolated bispecific antibodies with native immunoglobulin format
CN103033628A (zh) * 2012-12-18 2013-04-10 北京科技大学 制备个体全蛋白质组芯片的方法及其应用
MA43987A (fr) * 2015-05-12 2018-12-19 Regeneron Pharma Détermination de la pureté de protéine multimère
GB201603291D0 (en) * 2016-02-25 2016-04-13 Binding Site Group The Ltd Antibodies
US10209218B2 (en) * 2017-03-30 2019-02-19 908 Devices Inc. Microfluidic analysis of biological samples

Also Published As

Publication number Publication date
MX2021009267A (es) 2021-09-10
US20200249241A1 (en) 2020-08-06
IL284929A (en) 2021-09-30
AU2020216172A1 (en) 2021-08-05
JP2022519246A (ja) 2022-03-22
CN113646638A (zh) 2021-11-12
CN113646638B (zh) 2024-05-24
KR20210122803A (ko) 2021-10-12
WO2020160266A1 (en) 2020-08-06
CA3126712A1 (en) 2020-08-06
BR112021013716A2 (pt) 2021-09-21
EP3918339A1 (en) 2021-12-08

Similar Documents

Publication Publication Date Title
IL284929A (en) Original microfluidic ce-ms analysis of antibody charge heterogeneity
EP3433277A4 (en) NEW ANTIBODIES AGAINST PD-L1
BR112015022260A2 (pt) anticorpo monoclonal, polinucleotídeo, composição farmacêutica, fragmento isolado de tau, uso de um anticorpo, método de triagem de um agente e ácido nucleico
EP3165923A4 (en) Marker, immunoassay method, immunoassay reagent, method for assaying analyte, kit for assaying analyte, and test strip for lateral flow chromatography
SG11202009930PA (en) Microfluidic method for single cell analysis
EP3270152A4 (en) KIT FOR SAMPLE PREPARATION FOR THE DETECTION OF MONOCLONAL ANTIBODIES
GB201820554D0 (en) BTLA antibodies
BR112018015034A2 (pt) sistema de marcação de massa carregada
GB201802338D0 (en) Antigen binding proteins
IL276623A (en) Dosing regimens of B7-H4 antibody
EP3757575C0 (en) METHOD OF OPERATING AN ANALYTICAL LABORATORY
EP3821230C0 (en) FLUID SAMPLE ANALYSIS SYSTEM
HUE053453T2 (hu) Immunesszé teljesvér-mintákhoz
GB201919294D0 (en) Antibodies or binding proteins
EP3872491A4 (en) TEST SAMPLES FOR IMMUNOCHROMATOGRAPHY
IL281796A (en) Quantification of antibody in biological samples
EP4034568A4 (en) NOVEL ANTI-PD-L1 ANTIBODIES
SG11201607148QA (en) Urine sample analysis method and reagent kit for urine sample analysis
IL277510A (en) Anti-137CD antibodies for combination with anti-L1-PD antibodies
GB201910138D0 (en) Anti-pd-l1 antibodies
IL291660A (en) Natural mass spectrometry coupled to hydrophobic interaction chromatography for antibody analysis
EP3325973A4 (en) MEASURING LUMINESCENCE OF BIOLOGICAL SAMPLES USING DOUBLE REAGENTS
EP3624791A4 (en) REAGENT FOR BIOCONJUGATION, SELECTIVE TO A SPECIFIC SITE, PROTEINS OR ANTIBODIES
GB2579810B (en) Assay Analysis
EP3112863A4 (en) Method for urine sample analysis, reagent for urine sample analysis, and reagent kit for urine sample analysis